Indian Market Outlook- 23 June 2021
Total Page:16
File Type:pdf, Size:1020Kb
Market Outlook- 23 June 2021 On Tuesday, banks and financials succumbed to profit- Bharti Airtel gained 0.7 percent and TCS added 0.9 taking at higher levels, bringing Indian stocks down from percent after they announced a collaboration to build 5G their day's highs. IT companies and automakers made networks in India. gains, helping key benchmark indices finish the day in the black. India's record vaccine rollout of 8.3 million shots boosted investor confidence, as did a comeback in global markets On strong global signals, the 30-share BSE Sensex from four-week lows. The indexes were pulled down by soared to a record high of 53,057 earlier in the day before losses in financial companies and Reliance Industries, as giving up all of its early gains to end the day up 14.25 well as a broader retreat in global markets.. points. India designated a novel coronavirus variety to be of After scaling a record high of 15,895 earlier in the day, the concern on Tuesday, citing over two dozen cases in three states. broader NSE Nifty index closed up 26.25 points, or 0.17 percent, at 15,772.75. According to NK Arora, the head of India's National Technical Advisory Group on Immunization, the After reporting an 8% drop in Q4 profit, Oil India fell 0.6 government has enough Covid vaccine supply, with 200- percent. 220 million doses available starting next month (NTAGI). Arora told ET that the goal is to vaccinate at least 10 Maruti Suzuki India's stock jumped 5.2 percent after the million people per day. automaker announced it would raise its car prices starting in July. SBI Life, Wipro, Shree Cement, and UPL all increased by 2-4 percent, while Hindustan Unilever, Nestle India, Bajaj Finance, and Asian Paints all declined by 1-2 percent. IOB and the Central Bank of India both touched new 52-week highs before finishing with gains of 5.1 percent and 3.7 percent, respectively. Top Gainers Top Losers Company Last Price Change% Company Last Price Change% MARUTI 7,257.50 5.18% ASIANPAINT 3,015.00 -1.75% UPL 802.00 3.86% BAJFINANCE 6,018.00 -1.60% SHREECEM 29,161.15 3.32% NESTLEIND 17,430.00 -1.24% WIPRO 556.70 2.68% HINDUNILVR 2,487.00 -1.09% SBILIFE 1,005.00 2.39% INDUSINDBK 999.00 -0.85% Market Outlook- 23 June 2021 Disclaimer and General Advice Instructions: This document is provided by Laverne Securities Pty Ltd T/as La Verne Investing the Corporate Authorized Representative No. CAR No. 001269781 of La Verne Capital Pty Ltd AFSL 482937. The Research Analyst who prepared this report/article hereby certifies that the views expressed in this document accurately reflect the analyst’s personal views about the Company and its financial products. The information provided in the Report/Article is provided by Morningstar and FactSet. La Verne Fund is not a fund manager, however, the portfolio and the document is for general advice only, prepared by the Analysts and Research team for our clients. This report/article have Different Assumptions, Views, Analytical Method of the analyst with no guarantee of reliability and accuracy of the content. The Research Analyst has not been, is not, and will not be receiving direct or indirect compensation for expressing the specific recommendations or views in this report/article. La Verne Securities has its own Research methodology, with regards to the rating and is confirmed by the team for long term Strategic rating of the concerned security as an Investment for Portfolios with High Growth High Risk Profile. Individual Stock is Speculative and of High Risk in nature and strongly This Document is provided for the Advisors, their Clients, and Financial Professionals for information only and should not be considered an offer or solicitation of an offer to buy or sell a particular security or financial product or instrument. The information or services provided in this report/article may not be suitable for you and we strongly recommend taking the advice of your Financial Planner or Investment advisors. Laverne Investing will not treat the recipients as its customer by virtue of their receiving the report/article and should seek the advice of their consultant, prior to making any investment decision considering this report/article.